Navigation Links
Enrollment Begins on Human PK Study for Medidur(TM) FA
Date:8/22/2007

ATLANTA, Aug. 22 /PRNewswire-FirstCall/ -- Alimera Sciences, a privately held ophthalmic pharmaceutical company, and pSivida Limited (Nasdaq: PSDV, ASX: PSD, Xetra: PSI) today announced that enrollment has begun for the first human pharmacokinetic (PK) study of fluocinolone acetonide (FA) in Medidur(TM), the companies' investigational product for the treatment of diabetic macular edema (DME).

Medidur is a tiny insert, injected intra-vitreally during an in-office procedure, which is being studied as a way to deliver a very low dose of fluocinolone acetonide (FA), a corticosteroid, to the retina for up to three years as a treatment for DME. Medidur FA is currently in a Phase III global clinical trial, the FAME(TM) (Fluocinolone Acetonide in Diabetic Macular Edema) Study that will follow approximately 900 patients in the U.S., Canada, Europe and India for three years with safety and efficacy assessed at two years. Enrollment for this study has currently exceeded 750 patients.

This PK study is designed to support the FAME trial by providing pharmacokinetic/pharmacodynamic correlation data from DME patients. Sixteen patients are planned to be enrolled in this three-year, open label study. Samples of blood and aqueous humor (the fluid in the front of the eye) will be periodically taken to assess systemic and anterior chamber drug levels, respectively.

"Enrolling the same population in this study as in our FAME trial for DME will provide another important opportunity to learn more about the effect of FA on various aspects of this condition, as well as assess systemic drug levels," said Ken Green, PhD, Chief Scientific Officer for Alimera. "This study will also provide information on the location of Medidur
'/>"/>

SOURCE Alimera Sciences Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
2. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
3. Celsion Completes Enrollment in Phase I Liver Cancer Study
4. Testing for Human Papillomavirus
5. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
6. Phase II Results Show Once-Daily Dosing of Human GLP-1 Analog Liraglutide, Brings Patients to A1c Target
7. Apollos human proteins boost stem cell research
8. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
9. Modigene Announces Successful Completion of Pharmacokinetic & Pharmacodynamic Pre-Clinical Experiments for Proprietary Long-Acting Human Growth Hormone, Long-acting Interferon Beta and Long-acting Erythropoietin
10. Second Successful Quigley QR-443 Study Suggests Method of Action Relevant to Broad Range of Chronic Inflammatory Diseases - Human Study to Follow -
11. Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Gerons Human Embryonic Stem Cell-Based Therapeutic for Heart Failure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , Aug. 27, 2014 By now, if you ... not living on this planet. The awareness campaign has brought ... has helped to raise over $88.5 Million (and counting) for ... and some companies are starting to as well. ... Orlando, Florida , who actually works with ALS sufferers ...
(Date:8/27/2014)... CHICAGO , Aug. 27, 2014  Hill-Rom Holdings, ... listen to a management presentation at the Morgan Stanley ... p.m. EDT. You are invited to listen ... http://ir.hill-rom.com/events.cfm or access it directly at ... be available one hour after conclusion of the live ...
(Date:8/27/2014)... North American lighting leader OSRAM SYLVANIA ... the new OSRAM ITOS ® PHASER ® 3000, ... microscopy, endoscopy and surgical head lamps that delivers the same ... lamp life. "We,re honored to be recognized by ... new technologies of the past year," said Andreas Osten ...
Breaking Medicine Technology:Acorn Stairlifts Gives a Lift to the ALS Ice Bucket Challenge 2OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 2OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 3
(Date:8/27/2014)... in health care spending for commercially insured individuals is ... rather than increased use, according to a new study ... Policy & Clinical Practice, published in the August issue ... , There is increasing concern that consolidation in the ... by payers and, ultimately, consumers," said Carrie Colla, PhD, ...
(Date:8/27/2014)... 27, 2014 Scientists at The Scripps Research Institute ... signaling pathway can be associated with alcohol dependence. ... called neurofibromatosis type 1 (Nf1), which TSRI scientists found ... research shows Nf1 regulates gamma-aminobutyric acid (GABA), a neurotransmitter ... , "This novel and seminal study provides insights into ...
(Date:8/27/2014)... Dr. Winifred S. Hayes, President and CEO ... better health outcomes through the use of evidence, is ... to the executive team effective August 25, 2014. As ... responsible for providing innovation, leadership, and direction in the ... all markets. , “Maura is a highly respected ...
(Date:8/27/2014)... and dad, especially when your infant looks at you ... prattling, but by listening and responding, they let their ... forming complex sounds and using language more quickly. , ... of Iowa and Indiana University that found how parents ... way infants communicate and use vocalizations. , The findings ...
(Date:8/27/2014)... 2014 Will Holbrook, CP LP, has ... has over 15 years of experience in the prosthetics ... Georgia with a Bachelor of Science degree with a ... He received his graduate degree in prosthetics at Northwestern ... have Will join us at Fourroux,” says Keith Watson, ...
Breaking Medicine News(10 mins):Health News:Tracking spending among the commercially insured 2Health News:Scripps Research Institute scientists link alcohol-dependence gene to neurotransmitter 2Health News:Maura Connor Joins Hayes, Inc. as Vice President, Digital Publishing, Editor-in-Chief 2Health News:Parents, listen next time your baby babbles 2Health News:Parents, listen next time your baby babbles 3
... inadequate resources provided by the government to help the ... of treatment has left many stroke victims invalid. According ... with timely treatment and quality care. ,The ... victims with immediate brain scans, appropriate medication to dissolve ...
... a grant of $6 million for the Florida State ... for dyslexia in children.// The schedule involves understanding, ... grant will fund the creation of a National Institutes ... The center, which will be one of only four ...
... breast cancer who have been receiving the 30-year-old tamoxifen ... with the drug, Arimidex// under a new European licence ... AstraZeneca has stated that Arimidex, an aromatase inhibitor, will ... a partial course of tamoxifen.The license for this switch ...
... pass a law that would protect HIV/AIDS patient's rights to ... right// for a woman with the right to seek an ... ,India is supposedly the country with the highest number of ... this bill is being proposed to control this problem at ...
... the leading developmental disability. Statistics show that about 1.5 million ... a 10-17% increase in the disease ratio every year//. ... symptoms known to everyone the cause of the disease still ... brain developed by Dr. Stephen Grossberg, professor and chairman of ...
... taking part in an initiative to gauge if any ... who have suffered a stroke recently//. The MíTICO study ... Ictus. ,The study included patients from different Autonomous ... three months previously. By means of periodical controls, a ...
Cached Medicine News:Health News:Research Fund for FSU to Eradicate Dyslexia 2Health News:New Law On HIV/AIDS To Be Implemented At The Monsoon Session Of Parliament 2Health News:iSTART Brain Model Reveals the possible Cause of Autism 2Health News:iSTART Brain Model Reveals the possible Cause of Autism 3
Patent Pending lateral flow assay platform that contributes to increased sensitivty...
Iso-Electric Determination Kit; contains 1 bottle of 40 nm Naked Gold Iso-Electric Determination Kit to optimize gold conjugation of antibodies...
Gold Labeling kit for antibodies, the Coat-Block-Run Conjugation Kit pH 5-8; contains 1 bottle each of 20 nm and 40 nm Naked Gold...
Colloidal Gold Conjugated, Goat anti-rabbit IgG (H&L) - 50 OD...
Medicine Products: